Eleonora Teplinsky

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 272 citations · Full text

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care

Nathan A. Pennell, Melissa S. Dillmon, Laura A. Levit et al. · Journal of Clinical Oncology · 2020 · 84 citations · Full text

Nursing, Cancer Care Delivery, Health Policy +14

A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer

Komal Jhaveri, Rui Wang, Eleonora Teplinsky et al. · Breast Cancer Research · 2017 · 56 citations · Full text

Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy

Komal Jhaveri, Eleonora Teplinsky, Deborah Silvera et al. · Clinical Breast Cancer · 2015 · 54 citations · Full text

Breast Oncology, Neoadjuvant Chemotherapy, Immunology +9

EGFR and HER2: is there a role in ovarian cancer?

Eleonora Teplinsky, Franco M. Muggia · Translational Cancer Research · 2017 · 34 citations

Oncology, Medicine, Pharmacology +13